Viewing Study NCT00613093


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2026-01-19 @ 11:48 AM
Study NCT ID: NCT00613093
Status: COMPLETED
Last Update Posted: 2014-07-09
First Post: 2008-01-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
Sponsor: Duke University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module